Nuvilex Inc 

(Public, OTC:NVLX)   Watch this stock   
Find more results for NVLX

Key stats and ratios

Q3 (Jul '09) 2009
Net profit margin -1200.00% -925.11%
Operating margin -1151.47% -925.27%
EBITD margin - -920.83%
Return on average assets -50.81% -83.58%
Return on average equity -91.23% -105.74%
Employees 10 -

Address

1971 Old Cuthbert Road
Cherry Hill, NJ 08034
United States - Map
+1-856-4336088 (Phone)

Website links

Nuvilex Inc discussions

  View all discussions »

Description

Nuvilex, Inc. (Nuvilex), formerly eFoodSafety.com, Inc., is a holding company operating through its wholly-owned subsidiaries and is dedicated in bringing to market products designed to improve the health and well-being. Nuvilex manufactures Cinnergen, Cinnechol, Infinitink and Talysn. Nuvilex markets its products both directly and through wholesale and retail distribution partners. It is also engaged in the research and development of Oraphyte, a non-toxic, biodegradable nematocide for use on turfgrass and crops, as well as Citroxin, a multi-use germicidal composition with anti-viral properties. The Company engages seven full or part-time researchers. In July 2009, the Company commenced marketing its Last Shot Hangover Remedy product.

Officers and directors

Martin Schmieg
Chairman of the Board, Chief Executive Officer
Age: 47
Marylew Barnes
Chief Financial Officer, Senior Vice President, Secretary, Director
Age: 47
Robert Bowker
President of Knock-Out Technologies Ltd, Director
Age: 60
Richard M. Goldfarb M.D.
President of MedElite Inc, Director
Age: 55
Timothy Matula
Director
Age: 48